HomeProductsBioactive CompoundsJAK/STAT SignalingEGFRAnlotinib
Chemical structure of CAS 1058156-90-3

Anlotinib

CAS No.1058156-90-3
MDL No.N/A
MFC23H22FN3O3
MW407.40
InChI KeyKSMZEXLVHXZPEF-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1058156-90-3
Product NameAnlotinib

Biological Targets

PDGFRB·KIT·KDR·FLT4

Associated Conditions

hepatocellular carcinoma·lung neoplasm·essential tremor·pancreatic neoplasm·leiomyosarcoma·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Anlotinib as a molecular targeted therapy for tumors.

Oncology letters • Vol. 20, Issue 2 • 2020
PMID: 32724339PMC: PMC7377159DOI: 10.3892/ol.2020.11685

China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy.

Cancer communications (London, England) • Vol. 39, Issue 1 • 2019
PMID: 31221221PMC: PMC6585030DOI: 10.1186/s40880-019-0383-7

Documentation

Similar Products